What Questions Will Investors Actually Ask in Meetings?
29 March, 2026
29 March, 2026
Investor due diligence has a pattern once you’ve sat through enough of it. The questions change depending on the fund, the partner, and the stage, but the underlying concerns stay pretty consistent across all of them:
For non-technical founders, the product questions hit differently. You’re not just being evaluated on market insight. You’re being evaluated on whether you made sound technical decisions without a technical background, and investors know that’s a specific kind of vulnerability.
What follows is a guide to the questions you’ll face, what’s actually being tested underneath them, and what you can do before development begins to put yourself in a much stronger position when you’re sitting across from someone who’s heard a thousand of these pitches.
This section of diligence tends to feel biographical, but it isn’t really about your biography. Investors are trying to figure out whether your proximity to this problem is real enough and durable enough to carry you through the parts of building a company that aren’t exciting.
Investors fund locals, not tourists. They want to know whether your domain expertise is genuine enough to survive the slow, unglamorous parts of building a company, like the months when the product isn’t working, the users aren’t coming, and the only thing keeping you going is that you actually understand why this matters.
They’re also listening for whether your insight is specific or generic. ‘I’ve been in healthcare for 15 years, and I know this pain’ is a biography. ‘Every billing department I’ve ever worked with has the same problem, and the current tools solve the wrong part of it’ is evidence.
Founders who can answer these questions well have already encoded their expertise into their product. The workflows they prioritize, the user they serve first, or the features they’re willing to say no to are all visible expressions of domain knowledge. When investors ask, ‘Why you?’, the most credible answer points to concrete choices, not a resume.
This is where a lot of founders get tripped up. The surface-level question sounds easy. What problem are you solving? But investors are listening for specificity and for evidence that you’ve stress-tested your assumptions with real people, not just validated them with people who told you what you wanted to hear.
They want to know whether you can describe the problem more crisply than your users can. Founders who’ve done the research can. They can also tell you exactly which user segment feels the pain most sharply, and why that’s the right segment to start with. Founders who built first and validated second usually can’t, and it shows.
The ‘if your product disappeared’ question is particularly revealing. Founders with real problem clarity can answer it immediately, because they understand the specific inadequacy in whatever users would fall back to. Founders who don’t have that clarity tend to hesitate.
The product itself should reflect how well you understand the problem. If your MVP is solving for the wrong moment in the user’s workflow, or if the primary user journey is unclear, that’s a problem definition failure, and it shows up in the product whether you intend it to or not. Getting the problem brief and the first-pass user flows right before development begins is the highest-leverage thing you can do to prepare for this section of due diligence.
Investors at every stage are trying to figure out whether real users are voting with their time, their data, and their behavior, not just telling you what you want to hear in interviews. This section is less about your numbers and more about whether you know how to learn from what your product is telling you.
Whether you run experiments and adjust, or whether you cling to your original theory regardless of what the data says. Investors want founders who can talk about their numbers with clarity, including the uncomfortable ones, not defensiveness. Being able to say ‘here’s what we learned, here’s what we changed, and here’s what we still don’t know’ is more convincing than a clean story.
The question about who would be upset is worth preparing for seriously. A specific answer that names the kind of user, what they’d lose, and why they can’t easily replace it signals real product understanding. A vague answer signals the opposite.
Version one should be built to generate learning, not just to function. That means choosing features and flows that reveal user behavior, simple onboarding that shows where people drop off, in-product prompts that surface real objections, and enough instrumentation to understand who comes back and why. Founders who skipped this kind of intentional scoping often arrive at investor conversations with usage data that doesn’t tell them much.
This is where investors shift from evaluating the product to evaluating the business it’s meant to become. For non-technical founders, this section often feels more comfortable until the questions get specific and the answers start to depend on architectural decisions made months earlier.
Whether you understand the difference between a product and a business. More specifically: whether there’s a plausible path to software-level margins, or whether the economics quietly turn this into a services company at scale. Investors have seen enough products that work technically but don’t work economically to know this is a real failure mode.
They’re also looking for whether you’ve thought about the buyer-user distinction seriously. A product where the buyer is a CFO and the user is a frontline employee has a very different go-to-market from a product where they’re the same person, and the differences show up in everything from pricing structure to onboarding design to support cost.
Product decisions and business economics are more tangled than most founders realize. The onboarding model affects support costs. The level of automation determines gross margin ceiling. The architecture choices in version one either enable or constrain the pricing model you want to run eventually. These are conversations worth having before development starts, not after six months of building something that’s structurally difficult to defend.
The questions you’re not ready for usually trace back to pre-build decisions.
None of these is fatal on its own. But investors notice when a founder can’t explain the constraints in their own product, and even more when those constraints could have been avoided by a different set of early decisions.
Investor readiness and product readiness are the same thing, looked at from different angles. The founders who answer due diligence questions with confidence aren’t just better prepared for fundraising; they built something that generates real answers because they designed it to.
Whether you’re getting ready to raise, working through what to build next after your MVP, or figuring out how to tell the product story to a Series A investor, the underlying challenge is the same: the questions you can’t answer confidently usually trace back to decisions that weren’t made deliberately enough, or early enough. At Coura, we work with founders at all of those stages, helping them get clear on what the product is actually doing, where the gaps are, and how to talk about it to the people who matter.
Most founders who go through it say the same thing afterward: the questions they used to stumble on became the easy ones.